[Federal Register Volume 67, Number 59 (Wednesday, March 27, 2002)]
[Notices]
[Pages 14731-14732]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-7259]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacture of Controlled Substances; Notice of Registration

    By Notice dated September 24, 2001, and published in the Federal 
Register on October 3, 2001 (66 FR 50454), Roche Diagnostics 
Corporation, ATTN: Regulatory Compliance, 9115 Hague Road, 
Indianapolis, Indiana 46250, made application by letter to the Drug 
Enforcement Administration (DEA) to be registered as a bulk 
manufacturer of alphamethadol (9605) a basic class of controlled 
substance listed in Schedule I.
    Roche Diagnostics Corporation plans to manufacture small quantities 
of the above listed controlled substance for incorporation in drug of 
abuse detection kits.
    No comments or objections have been received. DEA has considered 
the factors in Title 21, United States Code, section 823(a) and 
determined that the registration of Roche Diagnostics Corporation, is 
consistent with the public interest at this time. DEA has investigated 
Roche Diagnostics Corporation on a regular basis to ensure that the 
company's continued registration is consistent with the public 
interest. These investigations have

[[Page 14732]]

included inspection and testing of the company's physical security 
systems, audits of the company's records, verification of the company's 
compliance with state and local laws, and a review of the company's 
background and history. Therefore, pursuant to 21 U.S.C. 823 and 28 CFR 
Sec. 0.100 and 0.104, the Deputy Assistant Administrator, Office of 
Diversion Control, hereby orders that the application submitted by the 
above firm for registration as a bulk manufacturer of the basic class 
of controlled substance listed above is granted.

    Dated: March 18, 2002.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 02-7259 Filed 3-26-02; 8:45 am]
BILLING CODE 4410-09-M